Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Apidra to Regular Insulin in Hospitalized Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects must be admitted to non-critical care units with expected length of stay of at least three days.~* Subjects must be able to communicate meaningfully with the investigator and must be legally competent to provide written informed consent.~* Subjects may be of either sex. Female subjects of child-bearing potential must be non-lactating and have a negative pregnancy test before starting the study.~* Subjects must be diagnosed with T2DM or develop hyperglycemia (BG \>180 mg/dl) during hospitalization.~Exclusion Criteria:~* Subjects must not be admitted for 'observation' or for expected length of stay of less than three days.~* Subjects must not have Type 1 Diabetes.~* Subjects must not be using rapid acting insulin analogues.~* Subjects must not be receiving nutrition via tube feedings.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Apidra (Type: ACTIVE_COMPARATOR): Direct 1:1 comparison of Apidra and Regular insulin.
- Regular (Type: ACTIVE_COMPARATOR): Direct 1:1 comparison of Apidra and Regular insulin.

Based on this trial design, predict the completion outcome and termination type (if applicable).